1. Home
  2. SELF vs IMA Comparison

SELF vs IMA Comparison

Compare SELF & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Self Storage Inc.

SELF

Global Self Storage Inc.

N/A

Current Price

$4.88

Market Cap

56.0M

Sector

Real Estate

ML Signal

N/A

IMA

ImageneBio Inc.

N/A

Current Price

$3.79

Market Cap

66.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SELF
IMA
Founded
1983
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.0M
66.3M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
SELF
IMA
Price
$4.88
$3.79
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$6.15
★ $18.00
AVG Volume (30 Days)
★ 19.1K
13.1K
Earning Date
11-06-2026
11-09-2026
Dividend Yield
★ 5.98%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.15
N/A
Revenue
★ $12,705,245.00
$800,000.00
Revenue This Year
$1.53
N/A
Revenue Next Year
$1.22
N/A
P/E Ratio
$32.37
★ N/A
Revenue Growth
★ 1.40
N/A
52 Week Low
$4.74
$3.00
52 Week High
$5.75
$7.60

Technical Indicators

Market Signals
Indicator
SELF
IMA
Relative Strength Index (RSI) 45.79 50.43
Support Level $4.80 $3.91
Resistance Level $5.26 $4.37
Average True Range (ATR) 0.09 0.31
MACD 0.01 0.02
Stochastic Oscillator 40.12 76.92

Price Performance

Historical Comparison
SELF
IMA

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

About IMA ImageneBio Inc.

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Share on Social Networks: